Ann: Trading Halt, page-152

A CR get's everyone in a state of flux, but isn't this the role of the share market ?
To help companies generate funds to pursue their endeavours.

The last raise was at 1.5c per share , roughly 14 months later, we raise at .26c a share.
Maybe in another 12 months we raise $500M at $4.20 per share ( same % increase ) for the acquisition of a small battery manufacturer.
Who knows, no doubt another state of flux will be generated.

What is the estimate for the Covid Art test, conservatively $10 per test with 50% profit margin of $5 per test for Anteotech.
What % of the cost of $5 would be the manufacturing charge to produce the test by Operon, maybe $3.50 - $4.00 per test .
We would need to pay Operon $4.0M per 1 million tests.
Do we have orders for 8M tests ?
Operon may well require a deposit for the first 4M tests, thanks very much. I know I would.

And yes, there are other ways to generate funds. But this is quick, minimal dilution, no overhanging costs/interest charges on the books.
Next 4 million .. we have a CFO to take care of that. Some clever debtor financing ? Who knows, there are numerous ways to generate funds.
But, for this initial order on Operon, this maybe the most pragmatic and straight forward way to get the $'s, particularly if funds were falling over themselves to get in.

Maybe something else completely.

Let's wait and see what Derek & the board have to say.

GLTAH